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Autologous veins remain the most commonly
used conduits for revascularization of occlusive arte-
rial lesions. Vein grafts universally develop wall thick-
ening in response to the new arterial hemodynamic
milieu. This process is at first adaptive. However, it
can also lead to graft failure, which occurs in up to
50% of the implanted vein grafts at 10 years.1,2 Wall
thickening is a result of the migration and prolifera-
tion of smooth muscle cells with deposition of extra-
cellular matrix in the intima and media of vein grafts.
Although the hemodynamic elements involved in
lesion formation are complex, studies have shown
that wall tension and shear stress are the two princi-
pal factors that modulate wall remodeling in vein
grafts.3-5
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Purpose: Hemodynamic alterations have been implicated as major stimuli for the develop-
ment of intimal hyperplasia in vein grafts that are implanted in the arterial circulation.
Tyrosine kinase is known to mediate cell signaling. However, its role with in vivo mechan-
otransduction is not yet well defined. We used a novel bioprosthetic collagen tube to pro-
vide an external support to vein grafts and examined the subsequent changes in hemody-
namics, tyrosine kinase signaling, wall remodeling, and vasomotor function.
Methods: Carotid interposition bypass grafting was performed with the reversed jugular vein
in New Zealand white rabbits. In the experimental group (n = 15), after the completion of
the proximal anastomosis, the vein was passed through a 4-mm collagen tube and the dis-
tal anastomosis was performed. The tube support was fashioned to completely cover the
vein grafts. The control animals (n = 14) had no tube support. After surgery, the blood pres-
sure and flow rate were measured and the wall tension and shear stress were calculated in
the vein grafts on day 3 or day 28 (n = 5 per group). Tyrosine phosphorylation was assessed
with the Western blot test in vein grafts at day 3 (n = 4 per group). The intimal and medi-
al dimensions of the vein grafts were assessed with videomorphometry on day 28 (n = 5 per
group). The cumulative dose response curves of the vein grafts to contractile and relaxant
agonists were determined in isometric tension studies on day 28 (n = 5 per group). 
Results: The use of tube support reduced wall tension 1.7-fold (P < .01) and increased
shear stress 4.8-fold (P < .001) without altering the flow rate or blood pressure. The
tyrosine kinase activity was reduced 15-fold (P < .001) in the tube-supported vein grafts.
The intimal thickness was reduced by 45% in the tube-supported vein grafts as compared
with the control grafts (46 ± 2 m m vs 84 ± 5 m m, respectively; P < .0001), and the media
thickness was reduced by 20% (63 ± 8 m m vs 79 ± 4 m m, respectively; P < .05). Isometric
tension studies showed preservation of contractile function and modulation of endothe-
lial-dependent dysfunctional relaxation in tube-supported vein grafts.
Conclusion: These results show that reduced wall tension and increased shear stress with
an external tube support can effectively modulate the signaling, functional, and hyper-
plastic responses in vein grafts. We conclude that this simple strategy deserves further
study and clinical consideration. (J Vasc Surg 1999;29:334-44.)
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In vitro models have provided invaluable insights
into the molecular mechanisms that link hemody-
namic forces to cellular responses.6-8 In particular,
tyrosine kinase mediation in endothelial cells has
been shown in the activation of mitogen-activated
protein kinases with shear stress9 and differential
endothelial responses to alterations in circumferen-
tial deformation and shear stress have been shown.10
Although much knowledge also has been gained
from in vivo models, the link between hemodynam-
ic elements and the induced events remain incom-
pletely defined as a result of the complexities of the
in vivo milieu. Schwartz et al5 demonstrated that
increased wall tension is the major stimulus for vein
graft wall thickening in the rabbit. Recently, Mehta
et al11 reported an increase in platelet-derived
growth factor–BB (PDGF-BB) expression in vein
grafts that was reduced with external stenting.
Various devices that circumferentially support vein
grafts have been used and shown to decrease wall
thickening in experimental models.4,11-14 The
hemodynamic, signaling, and functional alterations
that occur in vein grafts supported by these external
devices are, however, not yet well defined.
In this study, we used a novel, nonexpanding,
bioprosthetic collagen tube to provide an external
mechanical support to vein grafts. We then exam-
ined the changes in hemodynamics, tyrosine kinase
signaling, wall remodeling, and vasomotor function. 
METHODS
Experimental design. Twenty-nine New Zealand
white male rabbits underwent interposition bypass
grafting of the right common carotid artery with 
the reversed ipsilateral jugular vein as previously
described.15 In the experimental group (n = 15),
once the proximal anastomosis was performed, the
vein was passed through a collagen tube (diameter,
4 mm; length, 35 to 40 mm; Organogenesis,
Canton, Mass). The distal anastomosis then was
completed. The leaks were repaired, and the colla-
gen tube was fashioned to completely cover the vein
graft, including both anastomoses. The control ani-
mals (n = 14) were treated identically but without
tube support. After surgery, the flow rate and the
intraluminal blood pressure were measured on either
day 3 or day 28 (n = 5 per group). The vein grafts
were harvested on day 3 for an assessment of tyro-
sine phosphorylation with Western blot test (n = 4
per group) and on day 28 for scanning and trans-
mission electron microscopy, morphometric mea-
surement (n = 5 per group), and isometric tension
studies (n = 5 per group).
JOURNAL OF VASCULAR SURGERY
Volume 29, Number 2 Huynh et al 335
On the day of harvest, the animals were admin-
istered anesthesia and subsequently were killed with
an intravenous overdose of barbiturates as previous-
ly described.15 All the procedures performed on the
animals in this study were approved by the Duke
University Institutional Animal Care and Use
Committee. The animal care and handling complied
with the “Guide for the Care and Use of Laboratory
Animals.”16
Hemodynamic assessment. The rate of blood
flow was measured by applying flow probes (diame-
ter, 3 or 4 mm), which are connected to a flowmeter
(Transonic Systems, Inc, Ithaca, NY), to the external
surface of the vessels. Flow was measured with the
collagen tube in situ in tube-supported vein grafts.
The intraluminal blood pressure was measured with a
27-gauge needle, which was connected to a pressure
transducer and monitor (Propaq 106, Protocol
Systems, Inc, Beaverton, Ore). Flow rates and mean
blood pressures were determined in carotid arteries
(proximal and distal to the vein graft) and in vein
grafts immediately after implantation and at harvest
in a pilot study. There were no significant differences
in the flow rates or pressure levels in vein grafts
immediately after implantation, at harvest, or com-
pared with the proximal or distal segments of carotid
arteries. Thus, the measurements at harvest on day 3
or day 28 were used (n = 5 per group). Flow rates (in
mL/min) were measured from the mid segments of
vein grafts, and the mean arterial blood pressures (in
mm Hg) were measured from the proximal segments
of the carotid arteries.
Shear stress was calculated as t = 4h Q ÷ p ri3 in
dyne/cm2 (t , shear stress; h , blood viscosity; Q, flow
rate; ri, internal radius). Wall tension was calculated as
T = P·ri in 103 dyne/cm1 (T, wall tension; P, mean
arterial blood pressure; ri, internal radius). The blood
viscosity (0.03 in poise) was assumed to be constant.
The internal radius was determined with morphome-
try; we previously have demonstrated that the histo-
logic diameter underestimated the in situ diameter by
10%.5 For analytical purposes, the internal radius and
wall tension were recognized as approximations and
the flow of blood was assumed to be laminar. To nor-
malize the wall tension by wall thickness, the wall ten-
sile stress also was calculated (wall tensile stress = pres-
sure · internal radius ÷ wall thickness). Wall thickness
was defined as the sum of the thickness of the intima,
the media, and the collagen tube, respectively.
Protein extraction and Western blot test. On
the third day after surgery, the vein grafts (n = 4 per
group) were excised, cleared of adventitial tissues,
washed in ice-cold phosphate-buffered saline solu-
tion, cut into 1-cm rings, snap-frozen in liquid nitro-
gen, and stored at –80°C. Proteins were extracted
from the frozen samples by grinding the tissues to a
fine powder in a mortar and pestle in liquid nitrogen
followed by sonication in ice-cold RIPA (Santa Cruz
Biotechnology, Santa Cruz, Calif) lysis buffer (1:4
weight:volume; 50 mmol/L Tris-HCl, pH 7.4, 1%
Nonidet P-40, 0.25% sodium deoxycholate, 150
mmol/L NaCl, 1 mmol/L ethyleneglycol-tetra-
acetic acid, 1 mmol/L phenylmethylsulfonyl fluo-
ride, 1 mmol/L sodium orthovanadate, 1 mmol/L
sodium fluoride, 1 m g/mL aprotinin, 1 m g/mL leu-
peptin, and 1 m g/mL pepstatin). Insoluble debris
were pelleted in a microcentrifuge at 14,000g at 4°C
for 10 minutes. The supernatants were collected as
cell lysates and stored at –80°C until used. Protein
concentration was determined with the Bradford
assay (Biorad Laboratories, Richmond, Calif) with
0.2, 0.5, and 1.0 mg/mL of bovine serum albumin
(BSA) as the standard.
Equal amounts of protein extracts (15 m g) were
mixed in a gel loading buffer (1:4 volume:volume;
20% glycerol, 100 mmol/L Tris-HCl, pH 7.4, 100
mmol/L NaCl, 100 mmol/L dithiothreitol) and
boiled for 9 minutes. The samples then were loaded
onto an 8% sodiumolodecyl sulfate-polyacrylamide
minigel, separated by means of electrophoresis, 
and transferred onto a nitrocellulose membrane.
Nonspecific binding was blocked by incubating the
membrane in Tris buffered saline with Tween (TBST)
(10 mmol/L Tris-HCl, pH 8.0, 0.05% TWEEN-20
and 150 mmol/L NaCl), which contained 1% BSA,
overnight at 4°C. A monoclonal mouse antiphospho-
tyrosine antibody (PY20; 1 m g/mL; Chemicon
International Inc, Temecula, Calif) then was applied to
the blot for 1 hour at room temperature. Antibody
binding was detected by incubating the blot with a
horseradish peroxidase conjugated goat antimouse
immunoglobin G (1:5000 dilution; Santa Cruz
Biotechnology, Santa Cruz, Calif). The blot was
washed several times with TBST between the block-
ing steps. Finally, the blot was visualized with 
an enhanced chemiluminescence kit (Amersham,
Arlington Heights, Ill) and autoradiographed. The
autoradiographs were scanned and analyzed (Adobe
Photoshop 3.0, Adobe Systems, Inc, Mountain View,
Calif), and the integrated density of the visualized
bands was measured (NIH Image 1.61). The chemi-
cals were obtained from Sigma Chemical Company (St
Louis, Mo) unless otherwise stated.
Morphologic assessment. On the 28th day after
surgery, the vein grafts (n = 5 per group) were cleared
of blood with an initial infusion of Hanks Balanced
Salt Solution (Gibco Laboratories, Life Technologies,
Inc, Grand Island, NY) and then perfusion-fixed in
situ with 2% glutaraldehyde in a 0.1 mol/L cacodylate
buffer (pH 7.2), which was supplemented with 0.1
mol/L sucrose to give an osmolality of approximate-
ly 300 mOsm at a pressure of 80 mm Hg. After
immersion in the fixative for 48 hours, the cross-sec-
tions (3 per graft) from the middle segments of the
vein grafts were further processed either for scanning
and transmission electron microscopy or for morpho-
metric assessment as previously described.15 Briefly,
morphometric assessment was performed on the sec-
tions that were stained with a modified Masson stain
and Verhoeff’s stain. The intima and the media were
delineated by identification of the demarcation
between the criss-cross orientation of the hyperplastic
smooth muscle cells in the intima and the circular
smooth muscle cells of the media. The outer limit of
the media was defined by the interface between the
circular smooth muscle cells of the media and the
connective tissue of the adventitia. The luminal, inti-
mal, and medial areas of the entire cross-section of
each vein graft (3 sections per graft) were measured
by means of videomorphometry (Innovision 150,
American Innovision Inc, San Diego, Calif). The
internal radius and the thickness of the intima and
media of vein grafts were derived from each of the
measured luminal, intimal, and medial areas as previ-
ously described.17 The intimal ratio (intimal ratio =
intimal area ÷ [intimal + medial areas]) also was cal-
culated for each section. The value presented for each
parameter was the mean of all the cross-sections ± the
standard of the mean for the group (n = 5 grafts per
group).
After further specimen processing, a scanning
electron microscopic examination (Philips 500 scan-
ning electron microscope, N. V. Philips, Eindhoven,
The Netherlands) and a transmission electron micro-
scopic examination (Philips 300 transmission electron
microscope, N.V. Philips) were performed on the rep-
resentative mid sections as previously described.15
Isometric tension studies. The vein grafts were
sectioned into four 5-mm rings for in vitro isometric
tension studies on the 28th day after surgery. The
vasomotor function of the tube-supported vein grafts
is unknown at present. In the tube-supported group,
the collagen tubes were carefully dissected and
removed to allow unimpeded vessel contraction and
relaxation. Each ring was immediately mounted
between two stainless steel hooks in 5-mL organ baths
that contained oxygenated Krebs solution (122
mmol/L NaCl, 4.7 mmol/L KCl, 1.2 mmol/L
MgCl2, 2.5 mmol/L CaCl2, 15.4 mmol/L NaHCO3,
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mals survived until the end-points, and all the vein
grafts were patent at harvest.
Hemodynamics. The flow rates and pressures
were not significantly altered in the vein grafts with
tube support as compared with the control grafts
(Table I). With the application of the equations for-
mulated in the Methods section, the calculated wall
tension was decreased by 1.7-fold, and the shear
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1.2 mmol/L KH2PO4, and 5.5 mmol/L glucose,
maintained at 37°C and oxygenated with 95% O2 and
5% CO2) as previously described with some modifica-
tions.17 In brief, after equilibration, the resting tension
was adjusted in increments from 0.5 to 1.25 g and the
maximal response to a modified oxygenated Krebs
solution (60 mmol/L KCl, 66.7 mmol/L NaCl, 1.2
mmol/L MgCl2, 2.5 mmol/L CaCl2, 15.4 mmol/L
NaHCO3, 1.2 mmol/L KH2PO4, and 5.5 mmol/L
glucose) was measured to establish a length-tension
relationship. Cumulative dose response curves to the
contractile agonists norepinephrine (10-9 to 10-4
mol/L), serotonin (10–9 to 10–4 mol/L), and
bradykinin (10–9 to 10–5 mol/L) were constructed.
Relaxation responses to acetylcholine (10–8 to 10–4
mol/L), an endothelium-dependent agonist, and
nitroprusside (10–8 to 10–4 mol/L), an endothelium-
independent agonist, were assessed on rings precon-
tracted with norepinephrine, at the concentration that
produced 80% to 100% of maximal contraction. All the
rings were allowed to re-equilibrate for a minimum of
60 minutes between each experimental run, and the
same sequence of agonist testing was maintained for all
the experiments. All the chemicals were obtained from
Sigma Chemical Company.
The median effective concentration value for an
agonist, defined as the concentration that produces
the half maximal response for that agonist, was cal-
culated with logistic analysis for each ring. The sen-
sitivity of a vessel ring to an agonist was defined as
–log10 (median effective concentration value). The
standardized contractile ratio of each ring to an ago-
nist was defined as the maximal actual contractile
response to the agonist ÷ the contractile response to
60 mmol/L KCl. 
Statistical analysis. The values presented were
the mean ± the standard error of the mean for the
group. The unpaired Student t test was applied to
compare the differences in the hemodynamic assess-
ment, the Western blot test, and the functional data
between the two groups. For the morphometric
analysis, the differences were compared with the
Mann-Whitney test. A P value of less than .05 was
regarded as significant.
RESULTS
General results. One intraoperative death result-
ed from an unrecognized leak in the mid segment of
a tube-supported vein graft. This occurred in the early
stage of the project. All the subsequent leaks were rec-
ognized and repaired successfully. Otherwise, there
were no other significant complications, including
infection and bleeding, in either group. All the ani-
Fig 1. A, Representative Western blot test of phosphory-
lated tyrosine residues in control vein grafts (A and C)
and in tube-supported vein grafts (B and D). Molecular
weight markers (in kDa) are shown at left. Three days after
bypass graft surgery, phosphorylated tyrosine residues
were detected with PY-20 antibody (1 m g/mL; Chemicon
International, Inc, Temecula, Calif) in control vein grafts
in proteins at just above 82, 113, and 200 markers. Only
proteins with approximately 113 kDa molecular weight
were tyrosine phosphorylated in tube-supported vein
grafts. Samples were run in duplicate, and similar results
were found in other Western blot tests. B, Densitometric
analysis of protein bands (integrated density in relative
units) showed 15-fold reduction in tyrosine kinase activity
with tube support as compared with grafts without tube
support (control) by means of unpaired Student t test (P
< .001). Values are mean ± standard error of mean (n = 4
per group).
A
B
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stress was increased by 4.8-fold in the tube-support-
ed vein grafts as compared with the control grafts
(Table I). The decrease in wall tension was expected
because the pressure was not different, but the inter-
nal radius was reduced by 1.7-fold in the tube-sup-
ported vein grafts as compared with the control
grafts (1.63 ± 0.06 mm vs 2.69 ± 0.09 mm, respec-
tively; P < .0001). Similarly, the increase in shear
stress was anticipated because the flow was not sig-
nificantly changed and the shear stress is inversely
proportional to the third power of the internal
radius. The wall tensile stress was reduced 2.4-fold
in the tube-supported vein grafts as compared with
the control vein grafts (53.7 vs 131 · 106 dyne·cm-2,
respectively; P < .0001).
Tyrosine phosphorylation. We recently showed
that tyrosine phosphorylation is increased in vein grafts
(control) as compared with ungrafted jugular veins and
that this increase was inhibited by tyrphostin AG-51, a
tyrosine kinase inhibitor.18 In this study, the Western
blot test showed a 15-fold reduction (P < .001) in
phosphorylated tyrosine residues in the wall extracts of
tube-supported vein grafts at day 3 when compared
with control grafts (Fig 1). Phosphorylated tyrosine
residues were detected in approximately 113 kDa pro-
teins in tube-supported vein grafts (Fig 1A). In control
vein grafts (Fig 1A), however, in addition to the greater
amount of phosphorylated tyrosine residues in approx-
imately 113 kDa proteins, phosphorylated tyrosine
residues were also present in proteins with molecular
weights just above 82 kDa and of 200 kDa.
Morphology. Externally supporting the vein
grafts with the bioprosthetic collagen tube reduced
the internal (luminal) diameter of vein grafts at day
28 by 39% as compared with the control vein grafts
(3.27 ± 0.13 mm vs 5.39 ± 0.18 mm; P < .0001).
The thickness of the intima was decreased by 45%
(46 ± 2 m m vs 84 ± 5 m m; P < .0001), and the media
by 20% (63 ± 8 m m vs 79 ± 4 m m; P < .05) in the
tube-supported vein grafts as compared with the
control grafts, respectively (Fig 2A). Both the inti-
mal areas and the medial areas were also reduced, by
66% and 49%, respectively (Table II). As a result of
the greater reduction in intimal dimension relative
to the reduction in the media, the intimal ratio was
decreased by 10% (Table II). However, the luminal
index was maintained constant with or without tube
support, although the luminal area was reduced by
63% (Table II; Fig 2B).
Scanning electron microscopy results showed a
confluent endothelial lining with distinct cell borders
in both the tube-supported vein grafts (Fig 3A) and
the control vein grafts (Fig 3B). The endothelial cells
were unaltered and flattened in the tube-supported
vein grafts as compared with the more cuboidal and
bulging endothelial cells in the control vein grafts. The
vein grafts with tube support had less subendothelial
edema and less debris (Fig 4A) than did the control
Table I. Hemodynamic parameters
Parameter Tube-supported grafts Control grafts P value
Flow (mL·min–1) 12.8 ± 1.1 11.5 ± 1.0 .41
Pressure (mm Hg) 53.2 ± 3.8 57.8 ± 1.4 .29
Wall tension (· 103 dyne·cm–1) 11.7 ± 0.9 19.8 ± 0.5 <.01
Shear stress (dyne·cm–2) 1.9 ± 0.25 0.4 ± 0.04 <.001
Wall tension was calculated as T = P·ri. Shear stress was calculated as t = 4 h Q ÷ p ri3. T, Wall tension; P, blood pressure; ri, internal radius;
t , shear stress; h , blood viscosity (0.03 in poise); Q , blood flow.
Values are mean ± standard error of the mean (n = 5 per group).
Statistical differences between tube-supported vein grafts and control vein grafts were compared with unpaired Student t test.
Table II. Dimensional analysis of vein grafts at day 28
Parameter Tube-supported grafts Control grafts P value
Luminal area (mm2) 8.6 ± 0.6 23.2 ± 1.6 <.001
Intimal area (mm2) 0.48 ± 0.02 1.42 ± 0.08 <.001
Medial area (mm2) 0.70 ± 0.11 1.36 ± 0.07 <.001
Intimal ratio 0.46 ± 0.06 0.51 ± 0.01 <.01
Luminal index 34.1 ± 3.6 34.9 ± 2.2 .33
Intimal ratio, Intimal area/(intimal + medial areas); luminal index, luminal diameter/(intimal + medial thickness).
Values are mean ± standard error of the mean (n = 5 per group).
Statistical differences between tube-supported vein grafts and control vein grafts were compared with unpaired Mann-Whitney test.
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Fig 2. A, Representative composite photomicrograph of cross-sections from tube-supported
vein graft (A) and control vein graft (B). At 28 days, intimal thickness was decreased by 45%
in tube-supported vein grafts as compared with controls (46 ± 2 m m vs 84 ± 5 m m, respective-
ly; P < .0001). Thickness of the media also was decreased, although to a lesser extent (by 20%)
with tube support as compared with no tube support (63 ± 8 m m vs 79 ± 4 m m, respectively;
P < .05). Top is the lumen. Arrowheads delineate demarcation between intima and media.
Original magnification, · 250. H, Intimal hyperplasia; M, media; *, collagen tube. B, Schematic
diagram shows thickness of media (M) and intima (I) in relation to luminal diameter (D) in
tube-supported vein graft as compared with control vein graft. Luminal index = luminal diam-
eter ÷ (intimal + medial thicknesses). Note smaller diameter and lesser intimal and medial
thicknesses in tube-supported vein graft as compared with control vein graft (not to scale).
Table III. Vasomotor responses of vein grafts at day 28
Parameter Tube-supported grafts Control grafts P value
Norepinephrine 5.96 ± 0.07 5.97 ± 0.06 .91
Serotonin 6.39 ± 0.11 6.28 ± 0.07 .22
Bradykinin 6.32 ± 0.08 5.60 ± 0.09 <.001
Acetylcholine 3.92 ± 0.22 No response
Nitroprusside 6.46 ± 0.12 6.73 ± 0.19 .25
The concentration for the half maximal response (EC50) was calculated with logistic analysis, and the sensitivity was defined as
–log10(EC50). In each vein graft, the sensitivity was determined for each vessel ring (four rings per vein graft), and the mean was taken
as the value for that vein graft.
Values shown are mean ± standard error of the mean for the group (n = 5 per group).
Statistical differences between tube-supported vein grafts and control vein grafts were compared with the unpaired Student t test.
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grafts (Fig 4B), as seen with transmission electron
microscopy. In addition, the intimal smooth muscle
cells were orderly and circular in orientation and elon-
gated in shape with tube support (Fig 4A), whereas
the intimal smooth muscle cells in the control vein
grafts were disorganized and round-like (Fig 4B).
Vasomotor function. Tube-supported vein
grafts showed similar responses to KCl as compared
with controls (force, 300 ± 46 mg vs 280 ± 47 mg,
respectively; P = ns). The sensitivities of the tube-
supported vein grafts in response to norepinehrine
and serotonin were not significantly different than
that of the control grafts (Table III). The tube-sup-
ported vein grafts were, however, more sensitive to
bradykinin than were the control grafts (Table III).
The maximal contractile forces generated in response
to all three agonists (norepinephrine, serotonin, and
bradykinin), expressed as standardized contractile
ratios, were not significantly altered with the external
tube support of the vein grafts (Fig 5).
As previously reported,17 the control vein grafts
did not relax in response to acetylcholine (Fig 6A).
In contrast, 10 of the 20 rings from tube-supported
vein grafts showed dose-dependent relaxation in
response to acetylcholine, with a maximal relaxation
to 64% of precontracted tension (Fig 6A), albeit
with a low sensitivity (Table III). Of the five tube-
supported vein grafts studied, only one had no
response to acetylcholine in all rings. In response to
nitroprusside, the sensitivity (Table III) and maximal
relaxation (Fig 6B) were similar in the vein grafts
with or without tube support.
DISCUSSION
Vein grafts implanted in the arterial circulation
predictably develop wall thickening, with smooth
muscle cell hyperplasia and deposition of extracelullar
matrix in the intima and the media, an adaptive
process that has been referred to as “arterialization.”
In 50% of the implanted vein grafts, however, this
process becomes pathologic, usually as a result of
intimal hyperplastic lesions that cause either focal
stenosis or promote accelerated atherosclerosis.1
Until a significant improvement in the long-term
outcome of vein grafts is achieved, the search for bet-
ter wall remodeling will continue. This study shows
that by reducing wall tension and increasing shear
stress with an external tube support, the tyrosine
kinase signaling and subsequent wall remodeling
responses are effectively modulated in experimental
vein grafts.
Hemodynamic forces are known to play an
important role in the regulation of the cells that
compose the blood vessel wall. In particular, the
effects of shear stress on endothelial cells have been
studied extensively in vitro.6,8 Several shear
stress–inducible endothelial genes have been identi-
fied in vitro, including PDGF-AA, PDGF-BB, basic
fibroblast growth factor, and nitric oxide synthase,
all of which have been implicated in wound remod-
eling.8 The transformation of biomechanical (hemo-
dynamic) stimuli into biologic responses usually
begins with the activation of protein kinases and
protein-to-protein interactions that lead to gene
transcription (or inhibition thereof). Takahashi and
Fig 3. Scanning electron micrograph of representative tube-supported vein graft at day 28
(A) and control vein graft (B). Endothelial lining is confluent and cell borders are well defined
(arrowheads) in both vein grafts. Note unaltered and flattened shape of endothelial cells in
tube-supported vein graft. In contrast, endothelial cells are cuboidal and slightly bulging in
control vein graft. Arrows point to stomata. Original magnification, · 1250.
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Berk9 have demonstrated that shear stress can acti-
vate extracellular signal-regulated kinase via a tyro-
sine kinase-dependent pathway in cultured human
umbilical vein endothelial cells. The hemodynamic
factors in vivo are complex. However, the relative
importance of each factor has been identified in ani-
mal models.3,19
Our results showed that protein tyrosine kinase
activity is markedly reduced in vein grafts with
reduced wall tension and increased shear stress, both
of which are the consequences of the tube support.
The identity of the tyrosine phosphorylated proteins
(of approximately 82, 113, and 200 kDa) remains to
be further defined. However, we postulate that the
decreased tyrosine kinase activity in the tube-sup-
ported vein grafts may, in part, be associated with
the reduced expression or activation of the receptors
for growth factors, such as PDGF, fibroblast growth
factor, and epidermal growth factor. The receptors
for these growth factors have intrinsic protein tyro-
sine kinases, which range from 110 to 190 kDa in
molecular weight.20-22 Kraiss et al23 have shown that
an abrupt reduction in both blood flow and shear
stress is associated with increased PDGF-AA mes-
senger RNA and protein expression in baboon pros-
thetic grafts. In parallel, Mehta et al11 have recently
demontrated a significant decrease in PDGF-BB
protein with external stenting of vein grafts in the
pig model. Although wall tension and shear stress
were not assessed in the study of Mehta et al,11 their
external stent model likely produced hemodynamic
effects that were similar to the results of our tube
support model—that is, reduced wall tension and
increased shear stress.
Fig 4. Transmission electron micrograph of representative cross-section of tube-supported
vein graft at day 28 (A) and control vein graft (B). Endothelial cells (EC) are well defined in
both vein grafts. Intimal smooth muscle cells (SMC) are elongated and organized in several
layers in tube-supported vein graft as compared with more rounded-like and disorganized
smooth muscle cells in control vein graft. Also, there is more subendothelial edema (*) in con-
trol graft than in tube-supported vein graft. Original magnification, · 4500. L, Lumen.
JOURNAL OF VASCULAR SURGERY
342 Huynh et al February 1999
A multitude of hemodynamic factors are known
to influence wall thickening in vein grafts. Schwartz
et al5 have shown that “myointimal” (which refers to
both intima and media) thickening correlates most
strongly with wall tension in rabbit vein grafts. On
the other hand, Dobrin3 has demonstrated that inti-
mal thickening correlates best with low flow velocity
(a determinant of shear stress) and that medial thick-
ening is a better correlate of deformation in the cir-
cumferential direction (a determinant of wall ten-
sion). In this study, we found a greater reduction in
intimal thickening than in medial thickening, which
could be correlated with the larger increase in shear
stress and the smaller decrease in wall tension, respec-
tively, which supports the results from Dobrin.3
The tube support used in our model differs from
most of the stents used in other models of vein
grafts4,11,12,24 in that it is composed of collagen, which
was processed from porcine intestinal tracts. Because
of its biologic characteristics, the bioprosthetic colla-
gen tube would be incorporated into the host’s tissues,
remodeled, and eventually reabsorbed. Degradable
biomaterials would be void of the unwanted long-term
risks that are associated with prosthetic grafts. Zweep
et al13 have used a biodegradable prosthesis to support
rabbit vein grafts and have shown less disruption of the
Fig 5. Maximal contractile responses of tube-supported
(solid bar) and control (open bar) vein grafts to norepi-
nephrine, serotonin, and bradykinin. Both groups of vein
grafts generated similar contractile forces (tension) in
response to all three agonists. Contractile ratio = actual
maximal contraction to agonist (in mg) ÷ maximal con-
traction to 60 mmol/L KCl (in mg). Values are mean ±
standard error of mean (n = 5 per group). Unpaired
Student t test was used to compare results of two groups.
Fig 6. Dose-response curves for tube-supported (solid
bar) and control (open bar) vein grafts to acetylcholine
(A) and nitroprusside (B). Control vein grafts had no
response to acetylcholine (10–9 to 10–4 mol/L). Tube-
supported vein grafts, however, showed dose-dependent
relaxation to acetylcholine with maximal relaxation of 64%
of precontracted tension. Both tube-supported and con-
trol vein grafts responded to nitroprusside in dose-depen-
dent manner with maximal relaxation of greater than
100% of precontracted tension. Values are mean ± stan-
dard error of mean (n = 5 per group).
media, less edema, and less inflammation in the tube-
supported vein grafts. On the other hand, Okadome et
al25 have reported similar ultrastructural differences in
smooth muscle cell morphology and also less endothe-
lial ultrastructural alterations in a dog model of vein
grafts that were exposed to low versus high shear. Our
findings of unaltered endothelial configuration, less
wall edema, and a better organization of smooth mus-
cle cells with tube support of vein grafts would be con-
sistent with these prior studies.13,25
In this study, we report, for the first time, the
complete preservation of smooth muscle cell func-
tion and the recovery of endothelial-dependent
relaxation with tube support of vein grafts. Despite
the significant reduction in wall thickness, the tube-
supported vein grafts generated similar contractile
forces in response to KCl and all three of the con-
tractile agonists that were tested (norepinephrine,
serotonin, and bradykinin). Moreover, the increased
sensitivity to bradykinin in the tube-supported vein
grafts is consistent with a similar increase that was
observed in vein grafts treated with tyrphostin, a
tyrosine kinase inhibitor.18 Prior work from our lab-
oratory has shown that the rabbit jugular veins,
which were ungrafted, have a higher sensitivity to
bradykinin and a lower basal protein tyrosine kinase
activity as compared with the vein grafts, which were
untreated17,18; furthermore, after 2 weeks of expo-
sure to the arterial circulation, the vein grafts can
regain the higher sensitivity level to bradykinin when
reimplanted into the venous system.17 Taken togeth-
er, these findings could implicate protein tyrosine
kinases in the regulation of bradykinin receptors.
That relaxation to nitroprusside, an endotheli-
um-independent agonist, is preserved in tube-sup-
ported vein grafts is of no surprise—previous studies
have described this response in control vein grafts,
which were untreated. However, the recovery of
endothelium-dependent relaxation to acetylcholine
in 50% of the vessel rings with tube support would
indicate that endothelial function was in effect mod-
ulated. Increased shear stress has been shown to
stimulate increased production of nitric oxide in
vitro,6 which may explain in part the relaxation to
acetylcholine in the tube-supported vein grafts.
Systemic supplementation with L-arginine, the nitric
oxide precursor, has also been shown to preserve
endothelial-dependent relaxation of vein grafts to
acetylcholine.26 Improved endothelial function also
has been reported by Onohara et al27 with increased
prostacyclin production in vein grafts exposed to
high shear stress. Alternatively, the preserved
endothelial function in vein grafts may be attributed
to the lesser stretch injury with tube support. All in
all, endothelial cells are known to have a regulatory
role in smooth muscle cell proliferation and migra-
tion, in addition to its role in mechanotransduction
and vasomotor responses.1,8,20 We therefore postu-
late that improved endothelial function with tube
support may reduce the release of mitogenic and
chemoattractant signals, such as PDGF.
Although we have shown that the tube support of
vein grafts produces potentially beneficial wall remod-
eling and vasomotor responses at 28 days, the inter-
pretation of these results must be cautioned. First,
Fillinger et al28 have described some of the differences
between animal and human vein grafts, and the inter-
species comparison should be done with circumspec-
tion. Second, the reduction in the luminal diameter of
the tube-supported vein grafts may be undesirable if it
were flow-restrictive. We chose 4 mm as the diameter
of the collagen tubes because this approximated the
average diameter of the control vein grafts. Never-
theless, the measured flow was unimpeded with our
tube support model, and the luminal index, a measure
of wall remodeling, was similar with or without the
tube support. Other studies have suggested that vein
grafts adapt to the arterial circulation reaching an
equilibrium, at which point the ratio of the radius (or
luminal diameter) to wall thickness is maintained.28,29
Thus, unless this equilibrium is disturbed, the luminal
index should remain unchanged with or without tube
support. Last, the long-term in situ fate of the bio-
prosthetic collagen tubes ought to be determined in
future studies.
In summary, the results of our study show that
supporting vein grafts with an external bioprosthet-
ic tube optimizes the hemodynamic perturbations
and effectively modulates the subsequent signaling,
functional, and hyperplastic responses. We conclude
that this simple strategy deserves further experimen-
tation and clinical consideration.
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